Stay updated with breaking news from Lpcn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note issued to investors on Monday morning. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 4.5 % Shares of Lipocine stock opened at $3.65 on Monday. Lipocine has a 12 month low of $3.30 […]
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report issued on Monday morning. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 4.3 % Shares of NASDAQ LPCN opened at $3.82 on Monday. Lipocine has a twelve month low of $3.30 and a twelve […]
StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note published on Saturday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Lipocine stock opened at $4.16 on Friday. The stock has a market cap of $22.11 million, a price-to-earnings ratio of -1.75 and […]
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Up 1.4 % Shares of LPCN opened at $5.08 on Friday. Lipocine has a 12 month low of $3.30 and […]
Lipocine Inc. (NASDAQ:LPCN – Get Free Report) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $5.70 and traded as low as $4.90. Lipocine shares last traded at $5.01, with a volume of 25,765 shares traded. Analyst Ratings Changes Separately, StockNews.com began coverage on […]